Compositions and methods for preventing and treating endotoxin-related diseases and conditions

Details for Australian Patent Application No. 2004218358 (hide)

Owner Eisai Co. , Ltd.

Inventors McShane, James

Agent Spruson & Ferguson

Pub. Number AU-A-2004218358

PCT Pub. Number WO2004/078142

Priority 60/452,022 05.03.03 US

Filing date 5 March 2004

Wipo publication date 16 September 2004

International Classifications

C07D 303/22 Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom

Event Publications

15 September 2005 PCT application entered the National Phase

  PCT publication WO2004/078142 Priority application(s): WO2004/078142

13 March 2008 Assignment before Grant

  Eisai Co. , Ltd. The application has been assigned to Eisai R&D Management Co., Ltd.

1 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004218364-Diphenylethylene compounds and uses thereof

2004218354-Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof